KMI
81
2
PX
73
4
ALL
50
5
SO
57
7
VRTX
68
5
MKC
54
4
MSI
81
9
USB
53
3
CL
50
3
STI
17
10
SRE
68
4
LEN
55
6
URI
72
3
LYB
41
-2
EMN
50
-5
CMCSA
53
-11
DOW
35
-5
AMGN
47
3
FMC
41
-3
ED
46
3
KMI
81
2
PX
73
4
ALL
50
5
SO
57
7
VRTX
68
5
MKC
54
4
MSI
81
9
USB
53
3
CL
50
3
STI
17
10
SRE
68
4
LEN
55
6
URI
72
3
LYB
41
-2
EMN
50
-5
CMCSA
53
-11
DOW
35
-5
AMGN
47
3
FMC
41
-3
ED
46
3
Financhill
Back

Intellia Therapeutics Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
34

NTLA
Intellia Therapeutics

Last Price:
16.70
Seasonality Move:
10.47%
Buy
100

RYTM
Rhythm Pharmaceuticals

Last Price:
67.31
Seasonality Move:
9.98%
Sell
34
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $16.73. The Score for NTLA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $16.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $67.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 45.46 Sell
Chaikin Money Flow: 1491336 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.28 - 19.6) Sell
Bollinger Bands (100): (18.39 - 24.77) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 81.29 Buy
Chaikin Money Flow: 966983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.36 - 56.78) Buy
Bollinger Bands (100): (43.87 - 52.87) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.34 Buy
20-day SMA: 17.34 Sell
50-day SMA: 19.21 Sell
200-day SMA: 23.59 Sell
8-day EMA: 15.99 Buy
20-day EMA: 16.89 Sell
50-day EMA: 18.83 Sell
200-day EMA: 23.7 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.18 Buy
20-day SMA: 52.43 Buy
50-day SMA: 50.91 Buy
200-day SMA: 45.07 Buy
8-day EMA: 58.59 Buy
20-day EMA: 54.14 Buy
50-day EMA: 51.2 Buy
200-day EMA: 44.61 Buy

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.22 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):